INDIA – Gurugram-based Pathkind Labs has joined forces with Roche Diagnostics to release cardiac biomarker dubbed NTProBNP that will be used in the management of Type 2 Diabetes (T2DM). NTProBNP…
Read MoreTag: Roche
Roche scores world’s first companion diagnostic certificate under new EU regulation
SWITZERLAND — Roche has received the first In Vitro Diagnostic Regulation (IVDR) certificate for a companion diagnostic (CDx), according to TÜV SÜD Product Service, the notified body that assessed the…
Read MoreRoche’s bispecific antibody for lymphoma gets priority review from FDA
USA – The US Food and Drug Administration (FDA) has accepted Swiss drugmaker Roche’s bispecific antibody glofitamab for people with relapsed or refractory large B-cell lymphoma (LBCL). Glofitamab is an…
Read MoreAfrica secures partnerships for sustainable cervical and breast cancer programs
AFRICA – Roche and Jhpiego team up to help prevent or reduce the morbidity and mortality of women facing breast or cervical cancer in countries in Africa, taking a woman-centred…
Read MoreRoche Diagnostics Egypt introduces new initiative to advance lab diagnosis of heart failure
EGYPT – Roche Diagnostics Egypt has unveiled a new initiative dubbed ‘Peptide for Life’ in partnership with the Egyptian Society of Cardiology aimed at availing better health care for patients…
Read MoreRoche appoints Thomas Schinecker to be group CEO effective March 2023
SWITZERLAND — Roche has appointed Thomas Schinecker as the new group chief executive, the company has announced, replacing Severin Schwan whom the pharmaceuticals giant has nominated to be its next…
Read MoreRoche launches its molecular diagnostics system in Botswana
BOTSWANA – Industrial manufacturers of branded medicines Roche, in collaboration with Orthosurge Botswana and Diagnofirm, has inaugurated the cobas® 5800 molecular diagnostics system in Gaborone. The system will expand molecular…
Read MoreRoche’s Alzheimer’s drug fails to meet goal in clinical trials
SWITZERLAND — Roche Holding’s much-anticipated Alzheimer’s disease drug failed in two large studies, a new disappointment in a research field riddled with failures. The experimental drug, gantenerumab failed to slow…
Read MoreRoche sales slump more than expected in Q3 as COVID products slide
SWITZERLAND — Roche Holdings sales reached CHF14.74 billion (US$14.74 billion), down 6% year-over-year due to lower sales from COVID-19 treatments and diagnostics. “The third quarter of 2022 was particularly challenging…
Read MoreRoche Pharma sets up its second data analytics center in India
INDIA — Swiss multinational biotech giant Roche Pharma has set up a state-of-the-art Global Analytics and Technology Centre of Excellence (GATE) in Hyderabad, making it the company’s second data analytics…
Read More